• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叶酸受体介导的siRNA递送:RNA干扰疗法的最新进展与未来方向

Folate Receptor-Mediated siRNA Delivery: Recent Developments and Future Directions for RNAi Therapeutics.

作者信息

Gangopadhyay Sumit, Nikam Rahul R, Gore Kiran R

机构信息

Department of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur, India.

Department of Chemistry, University of Mumbai, Mumbai, India.

出版信息

Nucleic Acid Ther. 2021 Aug;31(4):245-270. doi: 10.1089/nat.2020.0882. Epub 2021 Feb 15.

DOI:10.1089/nat.2020.0882
PMID:33595381
Abstract

RNA interference (RNAi), a gene regulatory process mediated by small interfering RNAs (siRNAs), has made remarkable progress as a potential therapeutic agent against various diseases. However, RNAi is associated with fundamental challenges such as poor systemic delivery and susceptibility to the nucleases. Targeting ligand-bound delivery vehicles has improved the accumulation of drug at the target site, which has resulted in high transfection efficiency and enhanced gene silencing. Recently, folate receptor (FR)-mediated targeted delivery of siRNAs has garnered attention due to their enhanced cellular uptake and high transfection efficiency toward tumor cells. Folic acid (FA), due to its small size, low immunogenicity, high stability, and high binding affinity toward FRs, has attracted much attention for targeted siRNA delivery. FRs are overexpressed in a large number of tumors, including ovarian, breast, kidney, and lung cancer cells. In this review, we discuss recent advances in FA-mediated siRNA delivery to treat cancers and inflammatory diseases. This review summarizes various FA-conjugated nanoparticle systems reported so far in the literature, including liposome, silica, metal, graphene, dendrimers, chitosan, organic copolymers, and RNA nanoparticles. This review will help in the design and development of potential delivery vehicles for siRNA drug targeting to tumor cells using an FR-mediated approach.

摘要

RNA干扰(RNAi)是一种由小干扰RNA(siRNA)介导的基因调控过程,作为一种针对各种疾病的潜在治疗剂已取得显著进展。然而,RNAi存在一些根本性挑战,如全身递送效果不佳和易受核酸酶影响。靶向配体结合的递送载体提高了药物在靶位点的积累,从而导致高转染效率和增强的基因沉默。最近,叶酸受体(FR)介导的siRNA靶向递送因其对肿瘤细胞的细胞摄取增强和高转染效率而受到关注。叶酸(FA)因其体积小、免疫原性低、稳定性高以及对FRs的高结合亲和力,在靶向siRNA递送方面备受关注。FRs在包括卵巢癌、乳腺癌、肾癌和肺癌细胞在内的大量肿瘤中过表达。在本综述中,我们讨论了FA介导的siRNA递送在治疗癌症和炎症性疾病方面的最新进展。本综述总结了迄今为止文献中报道的各种FA缀合纳米颗粒系统,包括脂质体、二氧化硅、金属、石墨烯、树枝状聚合物、壳聚糖、有机共聚物和RNA纳米颗粒。本综述将有助于设计和开发潜在的递送载体,用于通过FR介导的方法将siRNA药物靶向肿瘤细胞。

相似文献

1
Folate Receptor-Mediated siRNA Delivery: Recent Developments and Future Directions for RNAi Therapeutics.叶酸受体介导的siRNA递送:RNA干扰疗法的最新进展与未来方向
Nucleic Acid Ther. 2021 Aug;31(4):245-270. doi: 10.1089/nat.2020.0882. Epub 2021 Feb 15.
2
Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.用于肝细胞癌治疗药物和小干扰RNA靶向递送的纳米颗粒
World J Gastroenterol. 2015 Nov 14;21(42):12022-41. doi: 10.3748/wjg.v21.i42.12022.
3
Systemic Delivery of Folate-PEG siRNA Lipopolyplexes with Enhanced Intracellular Stability for In Vivo Gene Silencing in Leukemia.具有增强细胞内稳定性的叶酸-聚乙二醇化小干扰RNA脂质多聚体的全身递送用于白血病的体内基因沉默
Bioconjug Chem. 2017 Sep 20;28(9):2393-2409. doi: 10.1021/acs.bioconjchem.7b00383. Epub 2017 Aug 24.
4
To Conjugate or to Package? A Look at Targeted siRNA Delivery Through Folate Receptors.共轭还是包装?审视通过叶酸受体进行的靶向小干扰RNA递送
Nucleic Acid Ther. 2021 Feb;31(1):21-38. doi: 10.1089/nat.2020.0893. Epub 2020 Oct 29.
5
Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.离子交联叶酸-聚(乙二醇)-壳寡糖乳酸纳米粒介导的高效siRNA递送及肿瘤蓄积:用于潜在的靶向卵巢癌基因治疗
Eur J Pharm Sci. 2014 Feb 14;52:48-61. doi: 10.1016/j.ejps.2013.10.011. Epub 2013 Oct 29.
6
Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.用于在KB肿瘤异种移植模型中递送合成小干扰RNA的叶酸连接脂质纳米颗粒。
Eur J Pharm Biopharm. 2008 Nov;70(3):718-25. doi: 10.1016/j.ejpb.2008.06.026. Epub 2008 Jul 4.
7
Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.叶酸修饰的聚酰胺-胺树枝状大分子在实体瘤中表现出高肿瘤摄取和持续高度局部保留:其用于局部小干扰RNA递送的效用。
Acta Biomater. 2017 Jul 15;57:251-261. doi: 10.1016/j.actbio.2017.04.023. Epub 2017 Apr 22.
8
Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies.叶酸偶联低相对分子质量壳聚糖用于体外 siRNA 递送:优化研究。
Int J Nanomedicine. 2012;7:5833-45. doi: 10.2147/IJN.S35567. Epub 2012 Nov 23.
9
Chemical and structural modifications of RNAi therapeutics.RNAi 治疗药物的化学和结构修饰。
Adv Drug Deliv Rev. 2016 Sep 1;104:16-28. doi: 10.1016/j.addr.2015.10.015. Epub 2015 Nov 5.
10
Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.用于递送基于合成RNA干扰疗法的阳离子液晶纳米颗粒。
Oncotarget. 2017 Jul 18;8(29):48222-48239. doi: 10.18632/oncotarget.18421.

引用本文的文献

1
Precision nanotherapeutics for kidney disease: targeting inflammation and maladaptive repair.用于肾脏疾病的精准纳米疗法:靶向炎症和适应性不良修复
Int Urol Nephrol. 2025 Sep 3. doi: 10.1007/s11255-025-04714-9.
2
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.推进纳米技术以改善癌症靶向治疗:克服其临床实施中的障碍。
Mol Cancer. 2023 Oct 9;22(1):169. doi: 10.1186/s12943-023-01865-0.
3
Computational design and validation of effective siRNAs to silence oncogenic KRAS.用于沉默致癌性KRAS的有效小干扰RNA的计算设计与验证
3 Biotech. 2023 Nov;13(11):350. doi: 10.1007/s13205-023-03767-w. Epub 2023 Sep 29.
4
Non-terminal conjugation of small interfering RNAs with spermine improves duplex binding and serum stability with position-specific incorporation.小分子干扰RNA与精胺的非末端缀合通过位点特异性掺入提高了双链体结合能力和血清稳定性。
RSC Adv. 2023 Aug 23;13(36):25169-25181. doi: 10.1039/d3ra04918c. eCollection 2023 Aug 21.
5
Correlation of several forms of folic acid with endometrial cancer: cross-sectional data from the National Health and Nutrition Examination Surveys (NHANES) 2011-2018.几种叶酸形式与子宫内膜癌的相关性:2011 - 2018年美国国家健康与营养检查调查(NHANES)的横断面数据
J Cancer Res Clin Oncol. 2023 Nov;149(15):13619-13629. doi: 10.1007/s00432-023-05177-0. Epub 2023 Jul 29.
6
Design of Folate-Containing Liposomal Nucleic Acid Delivery Systems for Antitumor Therapy.用于抗肿瘤治疗的含叶酸脂质体核酸递送系统的设计
Pharmaceutics. 2023 May 3;15(5):1400. doi: 10.3390/pharmaceutics15051400.
7
Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/STAT3 Pathway.叶酸修饰脂质体载白藜芦醇通过调控 JAK2/STAT3 通路抑制骨肉瘤生长及肺转移
Int J Nanomedicine. 2023 May 19;18:2677-2691. doi: 10.2147/IJN.S398046. eCollection 2023.
8
Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy.基于壳聚糖的纳米智能药物递送系统在乳腺癌治疗中的应用
Pharmaceutics. 2023 Mar 8;15(3):879. doi: 10.3390/pharmaceutics15030879.
9
Oral delivery of RNAi for cancer therapy.癌症治疗的 RNAi 口服递送。
Cancer Metastasis Rev. 2023 Sep;42(3):699-724. doi: 10.1007/s10555-023-10099-x. Epub 2023 Mar 27.
10
Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer.适配体可编程腺相关病毒载体作为细胞特异性基因转移的新型平台。
Mol Ther Nucleic Acids. 2023 Jan 21;31:383-397. doi: 10.1016/j.omtn.2023.01.007. eCollection 2023 Mar 14.